Alistair Wheeler

527 total citations
12 papers, 343 citations indexed

About

Alistair Wheeler is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Alistair Wheeler has authored 12 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in Alistair Wheeler's work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Pericarditis and Cardiac Tamponade (4 papers). Alistair Wheeler is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Pericarditis and Cardiac Tamponade (4 papers). Alistair Wheeler collaborates with scholars based in United States, Australia and Italy. Alistair Wheeler's co-authors include Thomas Goodin, Massimo Imazio, Antonio Abbate, David Lin, Antonella Insalaco, Antonio Brucato, Edward Kerwin, Martin M. LeWinter, Sushil Allen Luis and Paul Cremer and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Alistair Wheeler

12 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alistair Wheeler United States 7 160 117 85 75 68 12 343
Thomas d’Humières France 9 104 0.7× 37 0.3× 29 0.3× 17 0.2× 33 0.5× 22 225
Şaban Keleşoğlu Türkiye 12 212 1.3× 39 0.3× 63 0.7× 17 0.2× 18 0.3× 43 364
V. Pagliara Italy 8 183 1.1× 56 0.5× 56 0.7× 15 0.2× 33 0.5× 8 297
Agostino Buonauro Italy 11 176 1.1× 76 0.6× 29 0.3× 38 0.5× 27 0.4× 15 280
Refik Emre Altekin Türkiye 13 221 1.4× 100 0.9× 79 0.9× 107 1.4× 15 0.2× 31 356
Dragoș Traian Marius Marcu Romania 9 87 0.5× 41 0.4× 28 0.3× 14 0.2× 32 0.5× 37 231
Johan Formgren Sweden 5 287 1.8× 219 1.9× 51 0.6× 13 0.2× 13 0.2× 5 385
Fenny Berends Netherlands 6 74 0.5× 36 0.3× 64 0.8× 84 1.1× 37 0.5× 7 329
Pavlos Stougiannos Greece 11 201 1.3× 71 0.6× 31 0.4× 13 0.2× 28 0.4× 26 339
Michal Pořízka Czechia 9 111 0.7× 51 0.4× 70 0.8× 25 0.3× 20 0.3× 31 286

Countries citing papers authored by Alistair Wheeler

Since Specialization
Citations

This map shows the geographic impact of Alistair Wheeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Wheeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Wheeler more than expected).

Fields of papers citing papers by Alistair Wheeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Wheeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Wheeler. The network helps show where Alistair Wheeler may publish in the future.

Co-authorship network of co-authors of Alistair Wheeler

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Wheeler. A scholar is included among the top collaborators of Alistair Wheeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Wheeler. Alistair Wheeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Puurunen, Marja, Caroline Kurtz, Alistair Wheeler, et al.. (2023). Twenty-four-hour urine oxalate and risk of chronic kidney disease. Nephrology Dialysis Transplantation. 39(5). 788–794. 4 indexed citations
2.
Brucato, Antonio, Alistair Wheeler, Sushil Allen Luis, et al.. (2022). Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis. Heart. 109(4). 297–304. 10 indexed citations
3.
Cremer, Paul, David Lin, Alistair Wheeler, et al.. (2021). CARDIAC MAGNETIC RESONANCE IMAGING FOR GUIDING DECISION-MAKING ON TREATMENT DURATION: DATA FROM RHAPSODY, A PHASE 3 CLINICAL TRIAL OF RILONACEPT IN RECURRENT PERICARDITIS. Journal of the American College of Cardiology. 77(18). 1302–1302. 3 indexed citations
4.
Brucato, Antonio, Alistair Wheeler, Sushil Allen Luis, et al.. (2021). TAPERING AND DISCONTINUATION OF BACKGROUND THERAPIES DURING THE TRANSITION TO RILONACEPT MONOTHERAPY IN RHAPSODY, A PHASE 3 CLINICAL TRIAL OF RILONACEPT IN PATIENTS WITH RECURRENT PERICARDITIS. Journal of the American College of Cardiology. 77(18). 1576–1576. 1 indexed citations
5.
Klein, Allan L., Massimo Imazio, Paul Cremer, et al.. (2020). Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. New England Journal of Medicine. 384(1). 31–41. 194 indexed citations
6.
Ferguson, Gary T., et al.. (2017). In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(3). 162–169. 24 indexed citations
7.
Donohue, James F., Thomas Goodin, Robert Tosiello, & Alistair Wheeler. (2017). Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies. Respiratory Research. 18(1). 202–202. 6 indexed citations
8.
Ferguson, Gary T., Thomas Goodin, Robert Tosiello, Alistair Wheeler, & Edward Kerwin. (2017). Long-term safety of glycopyrrolate/eFlow® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study. Respiratory Medicine. 132. 251–260. 19 indexed citations
9.
10.
Donohue, James F., Nicola A. Hanania, Barry J. Make, et al.. (2014). One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD. CHEST Journal. 146(6). 1531–1542. 19 indexed citations
11.
12.
Bokesch, Paula M., Gábor Szabó, Hilary P. Grocott, et al.. (2011). A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial). Journal of Thoracic and Cardiovascular Surgery. 143(5). 1022–1029. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas d’Humières Breakdown of academic impact, for papers by Şaban Keleşoğlu Breakdown of academic impact, for papers by V. Pagliara Breakdown of academic impact, for papers by Agostino Buonauro Breakdown of academic impact, for papers by Refik Emre Altekin Breakdown of academic impact, for papers by Dragoș Traian Marius Marcu Breakdown of academic impact, for papers by Johan Formgren Breakdown of academic impact, for papers by Fenny Berends Breakdown of academic impact, for papers by Pavlos Stougiannos Breakdown of academic impact, for papers by Michal Pořízka
Rankless by CCL
2026